Risk factor
Poor trading liquidity
Profitability factor
Favourable analyst view
About
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor,...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV
Target Price
The average target price of INNOVACAP.NS is 1046 and suggests 50% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t
Buy
Sell